|
| Issue Date | Title | Author(s) |
| 2012 | 6-gingerol ameliorated doxorubicin-induced cardiotoxicity: Role of nuclear factor kappa B and protein glycation | El-Bakly, W.M. ; Louka, M.L. ; El-Halawany, A.M. ; Schaalan, M.F. |
| 2014 | Evaluation of matrix metalloproteinase-2 in lung cancer | Ali-Labib, R. ; Louka, M.L. ; Galal, I.H.E.-S. ; Tarek, M. |
| 2014 | Evaluation of nestin in lung adenocarcinoma: Relation to VEGF and Bcl-2 | Ahmed, M.B. ; Nabih, E.S. ; Louka, M.L. ; Abdel Motaleb, F.I. ; El Sayed, M.A. ; Elwakiel, H.M. |
| 2017 | Evaluation of serum fibrotic markers; CTGF, IL-17and TGF-β1 versus liver biopsy for detection of hepatic fibrosis in Egyptian patients with chronic hepatitis C | Kassim, S.K. ; Kamal, S.M. ; Shehata, H.H. ; Salib, M.M. ; Louka, M.L. ; Sallam, M.M. ; Nabegh, L.M. |
| 2016 | Expression of nucleostemin gene in primary osteoarthritis | Louka, M.L. |
| 2017 | Galectin 1 overexpression in breast cancer tissues: Relation to serum matrix metalloproteinase 2 and 9 activity | Louka, M.L. ; Said H ; Elsayed S |
| 2016 | Involvement of fibroblast-specific protein 1 (S100A4) and matrix metalloproteinase-13 (MMP-13) in CCl4-induced reversible liver fibrosis | Louka, M.L. ; Ramzy M |
| 2016 | Leptin gene microsatellite polymorphism: Relation to metabolic syndrome | Raafat Abdraboh, N. ; Louka, M.L. ; Sabry, I.M. |
| 2017 | MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia | Nabhan, M. ; Louka, M.L. ; Khairy, E. ; Tash, F. ; Ali-Labib, R. ; El-Habashy, S. |
| 2017 | Role of microRNA-7 and selenoprotein P in hepatocellular carcinoma | Tarek, M. ; Louka, M.L. ; Khairy, E. ; Ali-Labib, R. ; Zaky, D.Z. ; Montasser, I.F. |
| 2014 | Validation of analytical breast cancer microarray analysis in medical laboratory | Darweesh, A.S. ; Louka, M.L. ; Hana, M. ; Rashad, S. ; El-Shinawi, M. ; Sharaf-Eldin, A. ; Kassim, S.K. |
